PHAXIAM Therapeutics S.A. (PHXM) — Working Capital to Net Assets Ratio
PHAXIAM Therapeutics S.A. (PHXM) has a Working Capital to Net Assets ratio of -62.3% as of June 2024. Working capital of €-9.62 Million (current assets of €5.89 Million minus current liabilities of €15.51 Million) is measured against net assets of €15.45 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PHAXIAM Therapeutics S.A. (PHXM) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
PHAXIAM Therapeutics S.A. Working Capital to Net Assets (2012–2023)
This chart shows how PHAXIAM Therapeutics S.A.'s Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2023. As of June 2024, the ratio stands at -62.3%, reflecting working capital of €-9.62 Million against net assets of €15.45 Million EUR. Check tangible net worth ratio of PHAXIAM Therapeutics S.A. to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for PHAXIAM Therapeutics S.A. (2012–2023)
The table below presents the year-by-year Working Capital to Net Assets ratio for PHAXIAM Therapeutics S.A. from 2012 to 2023, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PHAXIAM Therapeutics S.A. stock valuation.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 3.7% | €955.00K | €25.61 Million | €16.22 Million | €15.26 Million | ▼ -128.1 pp |
| 2022 | 131.8% | €30.96 Million | €23.49 Million | €42.63 Million | €11.68 Million | ▲ +44.1 pp |
| 2021 | 87.7% | €20.04 Million | €22.84 Million | €40.05 Million | €20.00 Million | ▲ +11.3 pp |
| 2020 | 76.4% | €20.29 Million | €26.54 Million | €49.63 Million | €29.35 Million | ▲ +4.3 pp |
| 2019 | 72.1% | €61.70 Million | €85.56 Million | €81.58 Million | €19.88 Million | ▼ -16.7 pp |
| 2018 | 88.8% | €129.26 Million | €145.60 Million | €149.91 Million | €20.65 Million | ▼ -10.4 pp |
| 2017 | 99.2% | €179.96 Million | €181.42 Million | €191.57 Million | €11.61 Million | ▼ -2.3 pp |
| 2016 | 101.5% | €36.19 Million | €35.64 Million | €42.53 Million | €6.35 Million | ▲ +3.3 pp |
| 2015 | 98.3% | €46.31 Million | €47.13 Million | €51.93 Million | €5.62 Million | ▼ -0.2 pp |
| 2014 | 98.4% | €35.27 Million | €35.82 Million | €39.53 Million | €4.26 Million | ▼ -1.1 pp |
| 2013 | 99.5% | €13.52 Million | €13.59 Million | €17.04 Million | €3.51 Million | ▲ +140.8 pp |
| 2012 | -41.3% | €1.66 Million | €-4.03 Million | €9.14 Million | €7.48 Million | — |